CytoDyn Inc. General form for registration of securities under the Securities Act of 1933

General form for registration of securities under the Securities Act of 1933

Cover
- Cover Page
Financial Statements
Notes to Financial Statements
Accounting Policies
- Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details
Uncategorized

Commitments and Contingencies (Details)

v3.26.1

Commitments and Contingencies (Details) £ in Millions, shares in Millions			9 Months Ended	12 Months Ended
	Nov. 23, 2025 USD ($) shares	Apr. 03, 2024	Feb. 28, 2026 USD ($)	May 31, 2025 USD ($) item	Nov. 30, 2025 USD ($)	May 31, 2025 GBP (£)	May 31, 2024 USD ($)
Commitments and Contingencies
Legal settlement accrued			$ 12,745,000	$ 50,000	$ 16,500,000		$ 7,000
Class action lawsuit - settlement payable in cash	$ 500,000
Class action lawsuit - settlement payable in shares (in shares) \| shares	49
Side Letter Agreement With Samsung
Commitments and Contingencies
Contractual obligation, percentage of qualifying revenue agreed to pay		20.00%	20.00%
Amount of contractual obligation included in other liabilities			$ 43,600,000	43,600,000
Progenics Purchase Agreement
Commitments and Contingencies
Amount of milestone payments payable				$ 5,000,000
Percentage of royalty payable				3.50%
Amount payable upon filing BLA with FDA				$ 500,000
Amount payable upon FDA approval				500,000
Annual maintenance fees				$ 150,000
Progenics Purchase Agreement \| Royalty Payable in Initial 10 Years
Commitments and Contingencies
Percentage of royalty payable				5.00%
Lonza Agreement
Commitments and Contingencies
Number of contract manufacturers \| item				2
Annual license fee				$ 350,000		£ 0.3
Royalty on net sales (as a percent)				2.00%		2.00%

- Definition

Amount payable upon FDA approval.

+ References

No definition available.

+ Details

Name:	cydy_CollaborativeArrangementAmountPayableUponFdaApproval
Namespace Prefix:	cydy_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount payable upon filing BLA with FDA.

+ References

No definition available.

+ Details

Name:	cydy_CollaborativeArrangementAmountPayableUponFilingBlaWithFda
Namespace Prefix:	cydy_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of annual maintenance fees.

+ References

No definition available.

+ Details

Name:	cydy_CollaborativeArrangementAnnualMaintenanceFees
Namespace Prefix:	cydy_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of milestone payments payable.

+ References

No definition available.

+ Details

Name:	cydy_CollaborativeArrangementMilestonePaymentsPayable
Namespace Prefix:	cydy_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Percentage of royalty payable.

+ References

No definition available.

+ Details

Name:	cydy_CollaborativeArrangementRoyaltyPaymentPercentage
Namespace Prefix:	cydy_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of contractual obligation excluding non-contingent amount.

+ References

No definition available.

+ Details

Name:	cydy_ContractualObligationExcludingNoncontingentAmount
Namespace Prefix:	cydy_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Percentage of qualifying revenue generated in each calendar year based on which payment to be made for the contractual obligation due.

+ References

No definition available.

+ Details

Name:	cydy_ContractualObligationPercentageOfQualifyingRevenueAgreedToPay
Namespace Prefix:	cydy_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of annual license fee payable under the license agreement.

+ References

No definition available.

+ Details

Name:	cydy_LicenseAgreementAnnualLicenseFeePayable
Namespace Prefix:	cydy_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of cash payable for the settlement of litigation as per terms of a settlement agreement.

+ References

No definition available.

+ Details

Name:	cydy_LossContingencySettlementAgreementCash
Namespace Prefix:	cydy_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of shares issuable for the settlement of litigation as per terms of a settlement agreement.

+ References

No definition available.

+ Details

Name:	cydy_LossContingencySettlementAgreementShare
Namespace Prefix:	cydy_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of contract manufacturers.

+ References

No definition available.

+ Details

Name:	cydy_NumberOfContractManufacturers
Namespace Prefix:	cydy_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Potential royalty payment as percentage of net sales.

+ References

No definition available.

+ Details

Name:	cydy_PotentialRoyaltyPaymentAsPercentageOfNetSales
Namespace Prefix:	cydy_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_LitigationReserveCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-9

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 27
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482395/460-10-55-27

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=cydy_SideLetterAgreementWithSamsungMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=cydy_ProgenicsPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=cydy_RoyaltyPayableInInitial10YearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=cydy_LonzaLicenseAgreementAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: